Inflammatory bowel disease and osteoporosis

Scandinavian Journal of Gastroenterology

Volumn 32, Issue 12, 1997, Pages 1247-1255

  Andreassen, H ^a   Rungby, J ^b   Dahlerup, J F ^b   Mosekilde, L ^b  

^a KØGE HOSPITAL   (Denmark)

^b NONE

Author keywords

Bone formation; Bone mineral density; Bone resorption; Crohn's disease; Inflammatory bowel disease; Osteomalacia; Osteopenia; Osteoporosis; Ulcerative colitis

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CONJUGATED ESTROGEN; CORTICOSTEROID; GESTAGEN; VITAMIN D;

BONE MINERAL; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; HORMONE SUBSTITUTION; HUMAN; INTESTINE RESECTION; ORAL DRUG ADMINISTRATION; OSTEOMALACIA; OSTEOPOROSIS; PRIORITY JOURNAL; REVIEW;

EID: 0031452096     PISSN: 00365521     EISSN: None     Source Type: Journal    
DOI: 10.3109/00365529709028155     Document Type: Review

References (63)

1. Anonymous. Consensus development conference: diagnosis, prophylaxis and treament of osteoporosis. Am J Med 1994. p. 645-50.
2. Report of a WHO study group WHO technical report series 843. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis. Geneva: WHO; 1994.
3. Manolagas SC, Jilka RL. Bone marrow, cytokines and bone remodelling. N Engl J Med 1995;332:305-11.
4. Rungby J, Hermann AP, Mosekilde L. Epidemiology of osteoporosis. Drugs Aging 1995;6:470-8.
5. Kanis JA, McCloskey EV. Epidemiology of vertebral osteoporosis. Bone 1992;13:51-10.
6. Chapuy MC, Arlot ME, Duboeuf F, Brun J, Crouzet B. Arnaud S, et al. Vitamin D3 and calcium to prevent hip fractures in the elderly. N Engl J Med 1992;327:1637-42.
7. Cooper C, Atkinson EJ, O'Fallon W, Melton III LJ. Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res 1992;7:221-7.
8. Ross PD, Davis JW, Epstein RS, Wasnich RD. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. Ann Intern Med 1991;114:919-23.
9. Kotowicz MA, Melton LJ, Cooper C, Atkinson EJ, O'Fallon WM, Riggs LB. Risk of hip fracture in women with vertebral fracture. J Bone Miner Res 1994;9:599-605.
10. Gardsell P, Johnell O, Nilsson BE, Nilsson JÅ. The predictive value of fracture, disease and falling tendency for fragility fractures in women. Calcif Tissue Int 1989;45:327-30.
11. Melton LJ, Atkinson EJ, O'Fallon WM, Wahner HW, Riggs LB. Long-term fracture prediction by bone mineral assessment at different skeletal sites. J Bone Miner Res 1993;8:1227-33.
12. Gardsell P, Johnell O, Nilsson BE, Gullberg B. Predicting various fragility fractures in women by forearm densitometry: a follow-up study. Calcif Tissue Int 1993;52:348-58.
13. Cummings SR, Black DM, Nevitt MC, Browner W, Cauley J, Ensrud K, et al. Bone density at various sites for prediction of hip fractures. The Study of Osteoporotic Fractures Research Group. Lancet 1993;341:72-5.
14. Rigeaud D, Angel LA, Cerf M, Carduner MJ, Melchior J, Santier C, et al. Mechanisms of decreased food intake during weight loss in adult Crohn's disease patients without obvious malabsorption. Am J Clin Nutr 1994;60:775-81.
15. Vogelsang H, Klamert M, Resch H, Ferrenci P. Dietary vitamin D intake in patients with Crohn's disease. Wien Klin Wochenschr 1995;107:578-81.
16. Silvennoinen J, Lamberg-Allardt C, Kärkäinen M, Niemelä S, Lehtola J. Dietary calcium intake and its relation to bone mineral density in patients with inflammatary bowel disease. J Immunol Methods 1996;240:285-92.
17. Imes S, Pinchbeck BR, Thomson AB. Diet counseling modifies nutrient intake of ptients with Crohn's disease. J Am Diet Assoc 1987;87:457-62.
18. Felson DT, Zhang Y, Hannan MT, Anderson JJ. Effects of weight and body mass index on bone mineral density in men and women: the Framingham Study. J Bone Miner Res 1993; Suppl:567-73.
19. Reid DM. Corticosteroid-induced osteoporosis. In: Smith R, editor. Osteoporosis 1990. London: Royal College of Physicians of London; 1990. p. 99-117.
20. Thibaud D, Krige MA, Gillard-Berguer D, Jacquet AF, Goy JJ, Burchardt P. Cyclosporine induces high bone turnover and may constitute to bone loss after heart transplantation. Eur J Clin Invest 1996;26:549-55.
21. Hay JE, Lindor KD, Wiesner RH, Dickson ER, Krom RAF, Larusso NF. The metabolic bone disease of primary sclerosing cholangitis. Hepatology 1991;14:257-61.
22. MacDonald BR, Gowen M. Cytokines and bone. Br J Rheumatol 1992;31:149-55.
23. Silvennoinen JA, Lethola JK, Niemela SE. Smoking is a risk factor for osteoporosis in women with inflammatory bowel disease. Scand J Gastroenterol 1996;31:367-71.
24. Goldstein MJ, Gelzayd EA, Kirsner JB. Some observations on the hazards of corticosteroid therapy in patients with inflammatory bowel disease. Trans Am Acad Ophth Otol 1967. p. 254-61.
25. Genant HK, Mall JC, Wagonfeld JB, Horst JV, Lanzl LH. Skeletal demineralization and growth retardation in inflammatory bowel disease. Invest Rad 1977. p. 541-9.
26. Greenstein AJ, Janowitz Sachar DB. The extraintestinal complications of Crohn's disease and ulcerative colitis: a study of 700 patients. Medicine 1976;55:401-12.
27. Neef B, Höring E, Maier K-E. Gaisberg U.v.Schwere osteoporose bei einer jungen Patientin mit Morbus Crohn. Dtsch Med Wochenschr 1991;116:1055-60.
28. Cowan FJ, Parker DR, Jenkins HR. Osteopenia in Crohn's disease. Arch Dis Child 1995;7:255-6.
29. Cowan FJ, Warner JT, Dunstan FDJ, Evans WD, Gregory JW, Jenkins HRR. Inflammatory bowel disease and predisposition to osteopenia. Arch Dis Child 1997;76:325-9.
30. Teufel M, Meyer-Hohnloser K, Mörcke EM, Stubig U, Niessen KH. Nachuntersuchungen bei 60 kinder mit Colitis Ulcerosa und Morbus Crohn. Monatsschr Kinderheikd 1988;136:378-83.
31. Hylander E, Ladefoged K, Madsen S. Calcium balance and bone mineral content after small intestinal resection. Scand J Gastroenterol 1981;16:167-76.
32. Vogelsang H, Ferenci P, Woloszczuk W, Resch H, Herold C, Frotz S, et al. Bone disease in vitamin D deficient patients with Crohn's disease. Dig Dis Sci 1989;34:1094-99.
33. Compston JE, Judd D, Crawley EO, Evans WD, Evans C, Church HA, et al. Osteoporosis in patients with inflammatory bowel disease. Gut 1987;28:410-5.
34. Pigot F, Roux C, Chaussade S, Hardelin D, Pilleter O, Puy Montbrun de T, et al. Low bone mineral density in patients with inflammatory bowel disease. Dig Dis Sci 1992;37:1396-403.
35. Tromm A, Rickels K, Hüppe D, Wiebe V. May B. Osteopenie bei chronish entzündlichen darmkrankungen. Leber Magen Darm 1994;24:23-30.
36. Scarla SH, Minne HW, Lempert UG, Leidig G, Hauber M, Raedsch T. et al. Bone mineral density and calcium regulating hormones in patients with inflammatory bowel diseases (Crohn's disease and colitis ulcerosa). Exp Clin Endocrinol 1994;102:44-9.
37. Ghosh S, Cowen S, Hannan WJ, Ferguson A. Low bone mineral density in Crohn's disease but not in ulcerative colitis, at diagnosis. Gastroenterology 1994;107:1031-9.
38. Abitbol V, Roux C, Chaussade S, Guillemant S, Kolta S, Dougados M, et al. Metabolic bone assessment in patients with inflammatory bowel disease. Gastroenterology 1995;108:417-22.
39. Bernstein CN, Seeger LL, Sayre JW, Anton PA, Artinian L, Shanahan F. Decreased bone density in inflammatory bowel dsease is related to corticosteroid use and not disease diagnosis. J Bone Miner Res 1995;10:250-6.
40. Silvennoinen JA, Karttunen TJ, Niemela SE, Manelius JJ, Lehtola JK. A controlled study of bone mineral density in patients with inflammatory bowel disease. Gut 1995;37:71-6.
41. Andreassen H, Rix M, Hylander E. Osteoporosis in a Danish out-patient clinic: bone mineral measurements and biochemical markers [abstract 956]. Gut 1996;39 Suppl 3:A168.
42. Bjarnason I, Macpherson A, Mackintosh C, Buxton-Thomas M, Forgacs I, Moniz C. Reduced bone density in patients with inflammatory bowel disease. Gut 1997;40:228-33.
43. Jahnsen J, Falch JA, Aadland E, Mowinckel P. Bone mineral density is reduced in patients with Crohn's disease but not in patients with ulcerative colitis: a population based study. Gut 1997;40:313-9.
44. Motley RJ, Crawley EO, Evans C, Rhodes J, Compston JE. Increased rate of spinal trabecular bone loss in patients with inflammatory bowel disease. Gut 1988;29:1332-6.
45. Ryde SJS, Clements D, Evans WD, Motley T, Morgan WD, Evans C, et al. Total body calcium in patients with inflammatory bowel disease: a longitudinal study. Clin Sci 1991;80:319-24.
46. Clements D. Motley RJ, Evans WD, Harries AD, Rhodes J, Coles RJ, et al. Longitudinal study of cortical bone loss in patients with inflammatory bowel disease. Scand J Gastroenterol 1992;27:1055-60.
47. Roux C, Abitbol V, Chaussade S, Kolta S, Guillemant S, Dougados M, et al. Bone loss in patients with inflammatory bowel disease: a prospective study. Osteoporosis Int 1995;5: 156-60.
48. Motley RJ, Clements D, Evans WD, Crawley EO, Evans C, Rhodes J, et al. A four-year longitudinal study of bone loss in patients with inflammatory bowel disease. Bone Miner 1993;23: 95-104.
49. Staun M. Tjellesen L, Thale M, Schaadt O, Jarnum S. Bone mineral content in patients with Crohn's disease. A longitudinal study in patients with bowel resections. Scand J Gastroenterol 1997;32:226-32.
50. Compston JE, Horton LWL, Ayers AB, Tighe JR. Osteomalacia after small-bowel resection. Lancet 1978;1:9-12.
51. Driscoll RH, Meredith SC, Sitrin M, Rosenberg IH. Vitamin D deficiency and bone disease in patients with Crohn's disease. Gastroenterology 1982;83:1252-8.
52. Hessov L, Mosekilde L, Melsen F, Fadth S, Hulten L, Lund B, et al. Osteopenia with normal vitamin D metabolites after small-bowel resection for Crohn's disease. Scand J Gastroenterol 1984;19:691-6.
53. Croucher PI, Vedi S, Motley RJ, Garrahan JN, Stanton MR, Compston JE. Reduced bone formation in patients with Osteoporosis associated with inflammatory bowel disease. Osteoporosis Int 1993;3:236-41.
54. Silvenoinnen J, Risteli L, Karttunen T, Risteli J. Increased degradation of type I collagen in patients with inflammatory bowel disease. Gut 38:223-8.
55. Canalis E. Mechanisms of glucocorticoid action in bone: implications to glucocorticoid-induced osteoporosis. J Clin Endocrin Metab 81:3441-7.
56. Sonnenberg A, Ehms H, Sonnenberg GE, Strohmeyer G. 25-hydroxy-cholecalciferol serum levels in patients with Crohn's disease. Acta Hepatogastroenterol 1977;24:293-5.
57. Compston JE, Creamer B. Plasma levels and intestinal absorption of 25-hydroxyvitamin D in patients with small bowel resection. Gut 1977;18:171-5.
58. Silvennoinen J. Relationships between vitamin D, parathyroid hormone and bone mineral density in inflammatory bowel disease. J Int Med 1996;239:131-7.
59. Clements D, Compston JE, Evans WD, Rhodes J. Hormone replacement therapy prevents bone loss in patients with inflammatory bowel disease. Gut 1993;34:1543-6.
60. Vogelsang H. Prevention of bone mineral loss in patients with Crohn's disease by longterm oral vitamin D supplementation. Eur J Gastroenterol Hepatol 1995;7:609-14.
61. Sandström B, Aro A, Becker W, Lyhne N. Pedersen JI, Pörsdottir I. Nordiska näringsrekommendationer 1996. Nord 1996. Copenhagen: Nordiske Ministerråd; 1996.
62. Rutgeerts P, Løfberg R, Malchow H, Lamers C, Olaison G, Jewell D, et al. A comparison of budesonide with prednisolone for active Crohn's disease. N Engl J Med 1994;331:842-5.
63. Greenberg G, Feagan B, Martin F, Sutherlan LR, Thompson ABR, Williams NC, et al. Oral budesonide for the treatment of active Crohn's disease. N Engl J Med 1994;331:836-41.